Zosano Pharma (ZSAN) | |||
---|---|---|---|
1.06 -0.02 (-1.85%) | 01-25 16:00 | ||
Open: | 1.08 | Pre. Close: | 1.08 |
High: | 1.0887 | Low: | 1 |
Volume: | 5,331,368 | Market Cap: | 108M |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 1.092 - 1.097 | 1.097 - 1.102 |
Low: | 0.988 - 0.994 | 0.994 - 0.998 |
Close: | 1.052 - 1.061 | 1.061 - 1.068 |
Stock Technical Analysis | |
---|---|
Overall: | ![]() ![]() ![]() |
Target: | Six months: 1.53 One year: 1.79 |
Support: | Support1: 0.82 Support2: 0.52 |
Resistance: | Resistance1: 1.31 Resistance2: 1.53 |
Pivot: | 0.90 ![]() |
Moving Averages: | MA(5): 1.05 ![]() MA(20): 0.82 ![]() MA(100): 0.83 ![]() MA(250): 0.87 ![]() |
MACD: | MACD(12,26): 0.12 ![]() Signal(12,26,9): 0.09 ![]() |
%K %D: | %K(14,3): 68.93 ![]() %D(3): 71.62 ![]() |
RSI: | RSI(14): 69.15 ![]() |
52-Week: | High: 1.96 Low: 0.328 Change(%): -18.5 |
Average Vol(K): | 3-Month: 693758 10-Days: 1224203 |
Price, MAs and Bollinger Bands |
---|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ZSAN has closed below upper band by 21.2%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
Stock chart |
---|
![]() |
Financial Analysis | |
---|---|
Growth | ![]() |
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
Profitability | ![]() |
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
Solvency | ![]() |
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
Efficiency | n/a |
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
Stock Basics & Statistics | |
---|---|
Exchange: NASDAQ Capital Market | |
Sector: Healthcare | |
Industry: Biotechnology | |
Shares Out. (M) | 102.07 |
Shares Float (M) | 101.94 |
% Held by Insiders | 0.36 |
% Held by Institutions | 15.59 |
Shares Short (K) | 6850 |
Shares Short Prior Month (K) | 7850 |
Stock Financials | |
---|---|
EPS | -0.727 |
Book Value (p.s.) | 0.540 |
Profit Margin | |
Operating Margin | |
Return on Assets (ttm) | -35.8 |
Return on Equity (ttm) | -104.3 |
Qtrly Rev. Growth | |
Gross Profit (p.s.) | -0.249 |
Sales Per Share | |
EBITDA (p.s.) | -0.318 |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | -32.90 |
Levered Free Cash Flow (M) | -27.88 |
Stock Valuation | |
---|---|
PE Ratio | -1.46 |
PEG Ratio | |
Price to Book value | 1.96 |
Price to Sales | |
Price to Cash Flow | -3.29 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |